Please wait
Table of Contents

As filed with the Securities and Exchange Commission on June 19, 2009
Registration No. 333-
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
NXSTAGE MEDICAL, INC.
(Exact Name of Registrant as Specified in Its Charter)
     
Delaware   04-3454702
(State or Other Jurisdiction of Incorporation or   (I.R.S. Employer
Organization)   Identification No.)
     
439 South Union Street    
Lawrence, Massachusetts   01843
(Address of Principal Executive Offices)   (Zip Code)
2005 Stock Incentive Plan
(Full Title of the Plan)
Jeffrey H. Burbank
President and Chief Executive Officer
439 South Union Street
Lawrence, Massachusetts 01843

(Name and Address of Agent For Service)
 
(978) 687-4700
(Telephone Number, Including Area Code, of Agent For Service)
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
             
o Large accelerated filer   þ Accelerated filer   o Non-accelerated filer   o Smaller reporting company
        (Do not check if a smaller reporting company)    
CALCULATION OF REGISTRATION FEE
                                             
 
  Title of               Proposed Maximum     Proposed Maximum        
  Securities to be     Amount to be     Offering Price Per     Aggregate Offering     Amount of  
  Registered     Registered(1)     Share     Price     Registration Fee  
 
Common Stock, $.001 par value per share
    4,100,000(2)      $5.00 (3 )     $20,500,000 (3 )     $1,144      
 
 
(1)   In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
 
(2)   Consists of an additional 4,100,000 shares issuable under the 2005 Stock Incentive Plan as previously approved by the stockholders of NxStage Medical, Inc. on May 28, 2009.
 
(3)   Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Registrant’s Common Stock as reported on the Nasdaq Global Market on June 16, 2009.
 
 

 


TABLE OF CONTENTS

Item 8. Exhibits
SIGNATURES
INDEX TO EXHIBITS
Ex-5.1 - Opinion of Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Registrant
Ex-23.2 - Consent of Ernst & Young LLP


Table of Contents

STATEMENT OF INCORPORATION BY REFERENCE
     Except as otherwise set forth below, this registration statement on Form S-8 incorporates by reference the contents of the registration statement on Form S-8, File No. 333-149225, relating to the Registrant’s 2005 Stock Incentive Plan and 2005 Employee Stock Purchase Plan, the registration statement on Form S-8, File No. 333-130241, relating to the Registrant’s 1999 Stock Option and Grant Plan, 2005 Stock Incentive Plan and 2005 Employee Stock Purchase Plan, and the registration statement on Form S-8, File No. 333-141804, relating to the Registrant’s 2005 Stock Incentive Plan.
     Item 8. Exhibits.
     The Exhibit Index immediately preceding the exhibits is incorporated by reference.

-1-


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Lawrence, Massachusetts on this 19th day of June, 2009.
         
  NXSTAGE MEDICAL, INC.
 
 
  By:   /s/ Jeffrey H. Burbank    
    Jeffrey H. Burbank   
    President, Chief Executive Officer   
 
POWER OF ATTORNEY AND SIGNATURES
     We, the undersigned officers and directors of NxStage Medical, Inc., hereby severally constitute and appoint Jeffrey H. Burbank and Winifred L. Swan, and each of them singly, our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names in the capacities indicated below, the registration statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as officers and directors to enable NxStage Medical, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorneys, or any of them, to said registration statement and any and all amendments thereto.
     Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
         
Signature   Title   Date
 
       
/s/ Jeffrey H. Burbank
  Jeffrey H. Burbank
  President, Chief Executive Officer and Director
( Principal executive officer )
  June 19, 2009
 
       
/s/ Robert S. Brown
  Robert S. Brown
  Chief Financial Officer
( Principal accounting and financial officer )
  June 18, 2009
 
       
/s/ Philippe O. Chambon
  Philippe O. Chambon
  Director   June 12, 2009
 
       
/s/ Daniel A. Giannini
  Daniel A. Giannini
  Director   June 15, 2009
 
       
/s/ Earl R. Lewis
  Earl R. Lewis
  Director   June 15, 2009
 
       
/s/ Reid S. Perper
  Reid S. Perper
  Director   June 15, 2009

-2-


Table of Contents

         
Signature   Title   Date
 
       
/s/ Craig W. Moore
  Craig W. Moore
  Director   June 15, 2009
 
       
/s/ David S. Utterberg
  David S. Utterberg
  Director   June 12, 2009
 
       
/s/ Jonathan T. Silverstein
  Jonathan T. Silverstein
  Director   June 13, 2009

-3-


Table of Contents

INDEX TO EXHIBITS
     
Number   Description
 
4.1(1)
  Restated Certificate of Incorporation of the Registrant
 
   
4.2(1)
  Amended and Restated By-Laws of the Registrant
 
   
5.1
  Opinion of Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Registrant
 
   
23.1
  Consent of Wilmer Cutler Pickering Hale and Dorr LLP (included in Exhibit 5.1)
 
   
23.2
  Consent of Ernst & Young LLP
 
   
24.1
  Power of attorney (included on the signature pages of this registration statement)
 
(1)   Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-126711), and incorporated herein by reference.